This collaborative environment is the ideal setting to empower scientists with new technology to streamline workflows and propel breakthroughs in cell research. By placing our system at MBC BioLabs, we are able to contribute to the advancement of life sciences.” — Gary Pace, CEO of Cell Microsystems DURHAM, NORTH CAROLINA, UNITED STATES — Cell Microsystems Empowers […]

Delivers 2-4x increase in AAV titers across many serotypes, cell lines, growth media, and transfection reagents Significantly reduces production costs and doubles the doses that can be produced in a single bioreactor run MADISON, Wis. — Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy […]

Collaboration will boost capabilities to deliver cancer treatment within Thailand and to Southeast Asia by 2025 Genepeutic Bio is on track to receive Thai FDA approval for the treatment by end of 2024 Cytiva leadership team visit Genepeutic Bio’s manufacturing facility in Thailand With Cytiva’s FlexFactory biomanufacturing platform, Genepeutic Bio, a leader in Thailand’s life […]

The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy DURHAM, N.C. – BioSkryb Genomics, a pioneer in comprehensive single-cell multiomic research solutions, optimized a high-throughput workflow of BioSkryb’s ResolveDNA® Single-Cell Whole Genome Amplification technology on HP’s new D100 Single […]

Appointment will further foster the company’s ongoing strong commercial traction and strategic development OXFORD, England — iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions announced today the appointment of Dr. Michael Lutz as CEO and Director for Iota Sciences Ltd. He will also serve as Managing Director for Iota´s German […]

Hong Kong — Today, the Future Technology: AI Empowering Bioprocessing Development summit hosted by Great Bay Bio (hereinafter referred to as “GBB”) was successfully held at the Suzhou International Expo Center, where industry players gathered to celebrate the feast of technological innovation. At the summit, Great Bay Bio announced the official launch of its self-developed AI-enabled, […]

LAS VEGAS — Altogen Biosystems announced the launch of a new lungs-targeted in vivo transfection reagent. The reagent is crafted to transport small molecules, DNA, RNA, and proteins to the lungs tissue, aiming to treat lung diseases, including cystic fibrosis and lung cancer. The transfection reagent is a non-viral complex comprising nanoparticle-sized cationic liposomes that play […]

Zurich, Switzerland and Tokyo, Japan – InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s innovative product portfolio in Japan. This alliance, effective immediately, will see Cosmo Bio becoming the exclusive distributor of InSphero’s 3D cell-based assay solutions across the Japanese market. InSphero, a global pioneer in 3D cell culture and organ-on-chip technology, […]

Former Comecer exec succeeds current Chief Executive Officer and founder Massimo Bocchi to lead the next phase of commercial expansion BOLOGNA, Italy – CellPly, the pioneer in multiparametric single-cell analysis and automated potency testing for cell therapy, today announced the appointment of Emiliano Spagnolo to the role of CEO, starting from July 14, 2023. Spagnolo joins […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical […]